PharmaLogic and Ratio Therapeutics Expand Manufacturing Collaboration for Targeted Alpha Therapy Candidate VIA Q1 2026 Earnings Unaudited EPS Surprise Drives Modest Stock Uptick Vestas Stock Declines After Company Warns Margins Could Hit Low End of Guidance